QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 280 filers reported holding QIAGEN NV in Q2 2023. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,844,294 | +24.6% | 588,748 | +38.6% | 0.12% | +31.1% |
Q2 2023 | $19,129,690 | +25.1% | 424,821 | +27.6% | 0.09% | +18.4% |
Q1 2023 | $15,297,400 | +74.4% | 333,059 | +89.4% | 0.08% | +55.1% |
Q4 2022 | $8,770,437 | +400.9% | 175,866 | +314.7% | 0.05% | +444.4% |
Q3 2022 | $1,751,000 | +39.2% | 42,408 | +87.4% | 0.01% | +28.6% |
Q4 2021 | $1,258,000 | -64.5% | 22,633 | -66.9% | 0.01% | -69.6% |
Q3 2021 | $3,539,000 | +90.8% | 68,476 | +78.6% | 0.02% | +76.9% |
Q2 2021 | $1,855,000 | -87.6% | 38,347 | -89.0% | 0.01% | -92.4% |
Q2 2020 | $14,917,000 | +120.4% | 348,453 | +114.2% | 0.17% | -11.9% |
Q1 2020 | $6,768,000 | +336.4% | 162,681 | +254.5% | 0.19% | +546.7% |
Q4 2019 | $1,551,000 | +277.4% | 45,891 | +267.7% | 0.03% | +328.6% |
Q3 2019 | $411,000 | -18.5% | 12,480 | +0.8% | 0.01% | -53.3% |
Q1 2019 | $504,000 | -76.0% | 12,385 | -80.2% | 0.02% | -71.2% |
Q2 2017 | $2,101,000 | +89.6% | 62,673 | +63.9% | 0.05% | +92.6% |
Q1 2017 | $1,108,000 | – | 38,247 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |